Ardent Health (NYSE:ARDT) Given New $15.00 Price Target at Guggenheim

Ardent Health (NYSE:ARDT) had its price objective cut by Guggenheim from $18.00 to $15.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

A number of other equities analysts also recently issued reports on ARDT. Stephens cut their price target on Ardent Health from $21.00 to $17.00 and set an “overweight” rating for the company in a research note on Friday, November 14th. Truist Financial cut their target price on Ardent Health from $21.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday, November 14th. The Goldman Sachs Group started coverage on Ardent Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $19.00 price target for the company. Morgan Stanley restated an “equal weight” rating and set a $12.00 price objective (down from $22.00) on shares of Ardent Health in a research note on Friday. Finally, UBS Group assumed coverage on shares of Ardent Health in a research note on Wednesday, September 10th. They issued a “buy” rating and a $17.00 target price for the company. Six analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $15.25.

Ardent Health Price Performance

Shares of NYSE:ARDT opened at $8.72 on Tuesday. The company has a quick ratio of 2.00, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. Ardent Health has a twelve month low of $8.28 and a twelve month high of $17.34. The stock’s 50 day moving average is $13.60 and its 200-day moving average is $13.29. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of 6.02, a PEG ratio of 6.55 and a beta of 0.44.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.10. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.55 billion. Ardent Health had a net margin of 3.24% and a return on equity of 19.02%. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. Sell-side analysts forecast that Ardent Health will post 1.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Ardent Health by 368.9% in the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock worth $18,296,000 after acquiring an additional 1,046,845 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of Ardent Health by 75.6% in the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after purchasing an additional 703,739 shares in the last quarter. SageView Advisory Group LLC raised its position in shares of Ardent Health by 367.2% in the second quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock valued at $10,800,000 after purchasing an additional 621,430 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC purchased a new stake in shares of Ardent Health during the 3rd quarter valued at approximately $6,377,000.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.